Tamoxifen and ICI 182,780 increase Bcl-2 levels and inhibit growth of breast carcinoma cells by modulating PI3K/AKT, ERK and IGF-1R pathways independent of ERalpha.

Source:http://linkedlifedata.com/resource/pubmed/id/19002577

Download in:

View as

General Info

PMID
19002577